510.25 -6.95 (-1.34%)

56.61% Fall from 52W High

142.1K NSE+BSE Volume

NSE 13 Mar, 2025 3:31 PM (IST)

Analyst Upgrade
ICICI Securities maintains a 'Buy' rating on Akums Drugs with a target price of Rs 710 See details

Akums Drugs & Pharmaceuticals Ltd. share price target

Akums Drugs & Pharmaceuticals Ltd. has an average target of 710. The consensus estimate represents an upside of 39.15% from the last price of 510.25. View 8 reports from 8 analysts offering long-term price targets for Akums Drugs & Pharmaceuticals Ltd..

- This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
Date Stock Author LTP Target Price at reco
(Change since reco%)
Upside(%) Type Report Discuss
09 Feb 2025 Akums Drugs & Pharma ICICI Securities Limited
510.25 710.00 560.90
(-9.03%)
39.15
Buy
30 Jul 2024 Akums Drugs & Pharma SBI Securities
510.25
IPO Subscribe
29 Jul 2024 Akums Drugs & Pharma HDFC Securities
510.25
IPO Note
29 Jul 2024 Akums Drugs & Pharma KRChoksey
510.25
IPO Subscribe
29 Jul 2024 Akums Drugs & Pharma Ashika Research
510.25
IPO Note
29 Jul 2024 Akums Drugs & Pharma Ventura
510.25
IPO Subscribe
29 Jul 2024 Akums Drugs & Pharma Hem Securities
510.25
IPO Subscribe
29 Jul 2024 Akums Drugs & Pharma IDBI Capital
510.25
IPO Subscribe
* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.